O'Shaughnessy Asset Management’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5
Closed 1801
2021
Q3
$0 Sell
5
-9
-64% -$636 ﹤0.01% 2786
2021
Q2
$1K Hold
14
﹤0.01% 2430
2021
Q1
$1K Buy
14
+9
+180% +$610 ﹤0.01% 2196
2020
Q4
$0 Sell
5
-498
-99% -$26.8K ﹤0.01% 2143
2020
Q3
$24K Hold
503
﹤0.01% 1227
2020
Q2
$24K Hold
503
﹤0.01% 1120
2020
Q1
$23K Hold
503
﹤0.01% 916
2019
Q4
$29K Buy
+503
New +$29.9K ﹤0.01% 1071
2016
Q3
Sell
-7,376
Closed -$294K 921
2016
Q2
$294K Sell
7,376
-19,794
-73% -$712K 0.01% 419
2016
Q1
$918K Sell
27,170
-8,782
-24% -$274K 0.02% 281
2015
Q4
$1.22M Buy
35,952
+3,466
+11% +$108K 0.03% 269
2015
Q3
$967K Buy
32,486
+4,423
+16% +$138K 0.02% 307
2015
Q2
$797K Buy
+28,063
New +$748K 0.02% 330

Other funds holding IART

O'Shaughnessy Asset Management's IART Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Integra LifeSciences (IART) in Q4 2021, closing a stake of 5 shares.

O'Shaughnessy Asset Management first reported a position in IART in Q2 2015 and held it in 13 quarters. The position peaked at $1.22M in Q4 2015. 277 funds tracked by Wall St. Rank hold IART as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Integra LifeSciences position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 5 Integra LifeSciences shares in Q4 2021.
  • O'Shaughnessy Asset Management first reported a position in Integra LifeSciences in Q2 2015 and held it in 13 quarters.
  • O'Shaughnessy Asset Management's Integra LifeSciences position peaked at $1.22M in Q4 2015.
  • 277 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.